The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy

Author(s): Kenneth B.R. Ewan, Trevor C. Dale

Journal Name: Current Drug Targets

Volume 9 , Issue 7 , 2008

Become EABM
Become Reviewer
Call for Editor


There has been a surge of interest in the therapeutic targeting of the Wnt pathway following the demonstration that it is activated in a wide variety of tumors and that blocking aberrant signaling promoted tumor cell apoptosis or differentiation. This review describes recent therapeutic approaches and discusses potential opportunities for intervention at multiple levels within the Wnt pathway.

Keywords: Wnt, β-catenin, signaling, dysregulation, cancer, therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Published on: 01 March, 2012
Page: [532 - 547]
Pages: 16
DOI: 10.2174/138945008784911787
Price: $65

Article Metrics

PDF: 2